Search Within

David H Ilson

  1. "Epidemiology and Biostatistics"
Formats
  1. Meeting Abstract (54)
  2. Journal Article (45)
  3. Miscellaneous (1)
Groups
  1. Department of Medicine (100)
  2. Epidemiology and Biostatistics (100)
  3. Gastrointestinal Oncology Service (100)
  4. Solid Tumor Oncology Division (100)
  5. Center for Pancreatic Cancer Research (90)
  6. Biostatistics Service (86)

More Groups

People
  1. Yelena Janjigian (73)
  2. Geoffrey Ku (68)
  3. Marinela Capanu (65)
  4. David Kelsen (59)
  5. Joanne Chou (36)
  6. Laura Tang (35)

More People

Years
  1. 2025 (2)
  2. 2024 (2)
  3. 2023 (11)
  4. 2022 (8)
  5. 2021 (7)
  6. 2020 (5)

More Years

Publications
  1. Journal of Clinical Oncology (54)
  2. Annals of Surgical Oncology (5)
  3. Annals of Oncology (4)
  4. Annals of Surgery (4)
  5. Cancer (4)
  6. Clinical Cancer Research (4)

More Publications

Publishers
  1. American Society of Clinical Oncology (54)
  2. Springer (9)
  3. Oxford University Press (8)
  4. American Association for Cancer Research (7)
  5. Lippincott Williams & Wilkins (5)
  6. Wiley Blackwell (4)

More Publishers

Results (100)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase II study of FOLFOX plus regorafenib (REGO) in patients with unresectable or metastatic esophagogastric (EG) cancer
    Meeting Abstract

    Janjigian, Y. Y.; Ku, G. Y.; Chou, J. F.; Capanu, M.; Siebel, M.; Chalasani, S. B.; Boyar, M. S.; Goldberg, Z.; Desai, A. M.; Kelsen, D. P.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Genomic profiling of esophagogastric (EG) tumors in clinical practice
    Meeting Abstract

    Riches, J. C.; Schultz, N.; Ku, G. Y.; Imtiaz, T.; Kelsen, D. P.; Ilson, D. H.; Solit, D. B.; Berger, M. F.; Ladanyi, M.; Arcila, M. E.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Loss of human epidermal growth factor receptor 2 (HER2) expression in HER2-overexpressing esophagogastric (EG) tumors treated with trastuzumab
    Meeting Abstract

    Janjigian, Y. Y.; Riches, J. C.; Ku, G. Y.; Imtiaz, T.; Capanu, M.; Chou, J. F.; Kelsen, D. P.; Ilson, D. H.; Berger, M. F.; Vakiani, E.
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • A phase II study of afatinib in patients (pts) with metastatic human epidermal growth factor receptor (HER2)-positive trastuzumab refractory esophagogastric (EG) cancer
    Meeting Abstract

    Janjigian, Y. Y.; Ku, G. Y.; Ilson, D. H.; Boyar, M. S.; Capanu, M.; Chou, J. F.; Kelsen, D. P.; Imtiaz, T.; Berger, M. F.; Vakiani, E.
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Activity of genacitabine/5-FU combination in refractory esophagogastrie (EG) cancer
    Meeting Abstract

    Won, E.; Ilson, D. H.; Chou, J. F.; Capanu, M.
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • A phase II study of afatinib in patients (pts) with metastatic human epidermal growth factor receptor (HER2)-positive trastuzumab-refractory esophagogastric (EG) cancer
    Meeting Abstract

    Janjigian, Y. Y.; Capanu, M.; Imtiaz, T.; Kelsen, D. P.; Ku, G. Y.; Schattner, M.; Brown, K. T.; Ilson, D. H.; Solit, D. B.; Berger, M. F.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Activity of gemcitabine/5-FU combination in refractory esophagogastric (EG) cancer
    Meeting Abstract

    Won, E.; Ilson, D. H.; Chou, J. F.; Capanu, M.
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • FDG-PET scan after induction chemotherapy for esophageal squamous cell cancer (ESCC) to predict for outcomes after chemoradiation (chemoRT) and to guide salvage chemotherapy during RT
    Meeting Abstract

    Ku, G. Y.; Janjigian, Y. Y.; Kriplani, A.; Ong, L.; Rusch, V. W.; Bains, M. S.; Rizk, N. P.; Sarkaria, I. S.; Capanu, M.; Goodman, K. A.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Evaluation of PET response to neoadjuvant therapy for patients with gastric and GEJ adenocarcinoma
    Meeting Abstract

    Hernandez, J.; Beylergil, V.; Goldman, D.; Tang, L. H.; Ilson, D. H.; Downey, R.; Strong, V. E.; Shah, M.; Gonen, M.; Schoder, H.; more...
    Annals of Surgical Oncology (2014)

    Fulltext@MSK | Save
  • Phase II trial of cetuximab plus cisplatin and irinotecan in patients with cisplatin and irinotecan-refractory metastatic esophagogastric cancer
    Journal Article

    Janjigian, Y. Y.; Ku, G. Y.; Campbell, J. C.; Shah, M. A.; Capanu, M.; Kelsen, D. P.; Ilson, D. H.
    American Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save